Myostatin Lecture Notes

Myostatin Overview

  • Myostatin (Mstn) is an autocrine, paracrine, and endocrine factor that regulates muscle mass.

Vocabulary

Key Terms

  • Kinase: An enzyme that transfers a phosphate (PO4) group from one molecule to another; common in second messenger signaling.

  • TGFβ (Transforming Growth Factor Beta): A family of growth factors, including myostatin.

  • Mstn: Abbreviation for myostatin.

  • GDF (Growth and Differentiation Factor): A subclass of TGFβ; myostatin is GDF8 in vertebrates.

  • BMP (Bone Morphogenic Protein): Another subclass of TGFβ.

  • Activins: Another subclass of TGFβ.

  • ActRII: Activin type II receptor; a transmembrane receptor that binds activin and myostatin.

  • ALK (Activin-like Kinases): Family of kinases that bind to ActRII, forming an enzyme-linked receptor; phosphorylates Smad proteins.

  • Smads: Transcription factors involved in myostatin signaling. R-Smad is activated by myostatin, Co-Smad binds R-Smad, and I-Smad inhibits R-Smad.

  • Transcription Factor: Proteins that bind to DNA and regulate gene expression.

  • Akt: Protein kinase that promotes growth by activating pathways for protein synthesis.

  • Follistatin: Antagonizes activins and myostatin, acting as an autocrine, paracrine, and endocrine factor.

  • IGF (Insulin-like Growth Factor): Antagonizes myostatin action.

  • GASP: Antagonizes myostatin.

Myostatin and Muscle Development

I. Myostatin Mutations

  • Mstn Mutations: Discovered by knocking out GDF8 in mice, leading to larger muscles.

  • Double Muscle Cattle: Intentional breeding of cattle with natural myostatin mutations leads to increased muscle mass; specific mutations identified.

  • Human Cases: A human with non-functional myostatin showed prominent muscle development in infancy but had decreased muscle force generation.

II. Role of Myostatin

  • Peptide Hormone: Limits muscle size.

  • Regulation of Expression

    • Decreased by signals indicating muscle size is appropriate.

    • Increased by signals indicating muscle use is limited or muscle breakdown is needed.

  • Functioning Pathway: Conventional protein secretory pathway; myostatin is produced in the rough endoplasmic reticulum (RER), dimerized, and secreted as an inactive complex.

Mechanism of Action

III. Activation and Signaling

  • Binding and Activation: Myostatin binds to the ActRIIB/ALK receptor complex on muscle cells.

  • Phosphorylation of Smads: R-Smad2 and R-Smad3 phosphorylated, forming a complex with Co-Smad4 which translocates to the nucleus to regulate gene expression.

IV. Effects of Myostatin Signaling

  1. Inhibition of Protein Synthesis: This is achieved by inhibiting Akt, which promotes protein synthesis.

  2. Blocking Cell Differentiation: Inhibits satellite cell differentiation, preventing muscle repair and growth.

  3. Initiation of Protein Degradation: Triggers protein breakdown pathways, leading to muscle wasting.

Antagonism of Myostatin Effects

V. Counteracting Signals

  • ActRIIB Receptor Mutations: Prevent myostatin activation.

  • Increased Follistatin Expression: Blocks myostatin action even if normal myostatin and receptor are present.

  • IGF Activity: IGF activates Akt, counteracting the actions of myostatin.

VI. Evolutionary Perspective

  • Evolution of Myostatin: Myostatin (GDF8) evolved from a growth factor present in invertebrates and lower vertebrates; GDF11 has broader functions in invertebrates.